M
Monopar Therapeutics (MNPR)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Monopar Therapeutics (MNPR)
Monopar Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on the development of therapeutics designed to extend life or improve the quality of life for cancer patients. The Company's pipeline consists of Validive, camsirubicin, ... Read more
- USD37.88
- USD37.88
- USD33.76
- USD54.30
- -4.30%
- --
- 12.56k
- 23.32k
- 227M
- 1.72
- 698.30%
Stock News
4 hours ago
Announcement by Gerdau S.A. of Results of Cash Tender Offer for Any and All Outstanding 4.875% Notes due 2027 issued by Gerdau Trade Inc.
Yahoo
5 hours ago
ITA: Fly At Your Own Risk (Rating Downgrade)
SeekingAlpha
6 hours ago
Thornburg Small/Mid Cap Growth Fund Q1 2025 Commentary
SeekingAlpha
6 hours ago
Thornburg Small/Mid Cap Core Fund Q1 2025 Commentary
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
